Journal Mobile Options
Table of Contents
Vol. 23, No. 6, 1984
Issue release date: 1984
Eur Neurol 1984;23:435–448

Chorea and Systemic Lupus erythematosus

A Critical Review

Bruyn G.W. · Padberg G.
Department of Neurology, Academic Hospital Leiden, State University, Leiden, The Netherlands


A critical analysis of 52 cases of systemic lupus erythematosus (SLE) and chorea is presented. Choreatic movements occurred early in the course of the disease in most cases; the duration varied from several days to 3 years. No sex predominance was found and no relationship could be demonstrated between chorea and other neurological signs, or between chorea and other SLE manifestations. Also, the neuropathological findings offered no simple explanation for the emergence of chorea. Immunological pathomechanisms might be present.

 goto top of outline Author Contacts

G.W. Bruyn, MD, Academic Hospital Leiden, Department of Neurology, Leiden (The Netherlands)

 goto top of outline Article Information

Received: March 13, 1984
Accepted: March 22, 1984
Published online: January 31, 2008
Number of Print Pages : 14

 goto top of outline Publication Details

European Neurology

Vol. 23, No. 6, Year 1984 (Cover Date: 1984)

Journal Editor: Bogousslavsky, J. (Montreux)
ISSN: 0014–3022 (Print), eISSN: 1421–9913 (Online)

For additional information:

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.